74P Five-year survival outcomes of camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic NSCLC: A phase II studyJ-J. Yang, C. Huang, Y. Fan, H. Pan,J. Feng, L. Jiang, X. Li, X-Q. Liu, J-P. Xiong,Y. Zhao,Y. Cheng, R. Ma, J. Wang, Y. Wang,Y-H. Liu, D. Lin, X. Li,X. Ma, W. Shi,Y-L. WuESMO Open（2024）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
